LEPRI, GEMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.412
EU - Europa 3.149
AS - Asia 3.124
SA - Sud America 353
AF - Africa 90
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.319
RU - Federazione Russa 1.100
CN - Cina 864
SG - Singapore 792
IT - Italia 756
PL - Polonia 461
HK - Hong Kong 405
VN - Vietnam 277
KR - Corea 263
BR - Brasile 252
IE - Irlanda 195
SE - Svezia 155
BD - Bangladesh 121
FR - Francia 109
IN - India 105
DE - Germania 101
FI - Finlandia 97
JP - Giappone 90
GB - Regno Unito 63
CA - Canada 46
AU - Australia 40
ID - Indonesia 40
JO - Giordania 39
AR - Argentina 29
TR - Turchia 29
MX - Messico 27
IQ - Iraq 24
EG - Egitto 21
ES - Italia 21
EC - Ecuador 20
ZA - Sudafrica 16
CH - Svizzera 14
CO - Colombia 14
NL - Olanda 14
BO - Bolivia 11
CI - Costa d'Avorio 11
IL - Israele 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
UA - Ucraina 8
BE - Belgio 7
LT - Lituania 7
NG - Nigeria 7
PE - Perù 7
PK - Pakistan 7
VE - Venezuela 7
BJ - Benin 6
PT - Portogallo 6
RO - Romania 6
AT - Austria 5
CL - Cile 5
PY - Paraguay 5
RS - Serbia 5
SA - Arabia Saudita 5
TW - Taiwan 5
UZ - Uzbekistan 5
AL - Albania 4
AZ - Azerbaigian 4
KE - Kenya 4
KZ - Kazakistan 4
MY - Malesia 4
PH - Filippine 4
TN - Tunisia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DZ - Algeria 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
Totale 11.164
Salva come PNG Salva come JPEG
Città #
Santa Clara 953
Ashburn 653
Singapore 588
Warsaw 443
Hong Kong 351
Fairfield 281
Seoul 249
Hefei 237
Chandler 194
Dublin 189
San Jose 182
Beijing 158
Florence 138
Woodbridge 137
Seattle 118
Cambridge 108
Houston 101
Milan 95
Ho Chi Minh City 90
Wilmington 77
Los Angeles 75
Lawrence 70
Altamura 69
Moscow 63
New York 63
Buffalo 62
Lauterbourg 62
Rome 57
Princeton 56
Council Bluffs 51
Hanoi 51
Munich 50
Ann Arbor 48
Boston 46
Tokyo 45
Mumbai 41
The Dalles 40
Helsinki 39
Melbourne 38
Chicago 34
Kent 34
Jakarta 28
Shanghai 26
Clifton 24
Paris 23
Pune 23
Naples 22
São Paulo 22
Turku 22
Dallas 21
Turin 21
Boardman 18
Guayaquil 16
Katsushika 16
Koishikawa 15
Toronto 15
Da Nang 14
Lappeenranta 14
San Diego 14
Bengaluru 13
Bologna 13
London 13
Salt Lake City 13
Chennai 12
Dong Ket 12
Frankfurt am Main 12
Johannesburg 12
Phoenix 12
Redondo Beach 12
Tianjin 12
West Jordan 12
Abidjan 11
Falls Church 11
Montreal 11
Norwalk 11
Orem 11
Shenzhen 11
Charleston 10
Fiesole 10
Incheon 10
Medford 10
Bari 9
Bern 9
Cairo 9
Guangzhou 9
Haiphong 9
La Paz 9
Rio de Janeiro 9
Secaucus 9
Brooklyn 8
Catania 8
Düsseldorf 8
Genoa 8
Hải Dương 8
Mexico City 8
Abuja 7
Andover 7
Barnet 7
Cartagena 7
Manchester 7
Totale 7.199
Salva come PNG Salva come JPEG
Nome #
Systemic sclerosis: one year in review 2024 376
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 332
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 280
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 265
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 241
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 232
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 215
AB0976 Association of Vitamin D Receptor Polymorphisms with Juvenile Idiopathic Arthritis (JIA) 207
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 202
The Role of Adipokines between Genders in the Pathogenesis of Osteoarthritis 199
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 188
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 188
Evidence for a Derangement of the Microvascular System in Patients with a Very Early Diagnosis of Systemic Sclerosis 183
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 182
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 182
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 180
Systemic Sclerosis Association with Malignancy 176
Antioxidant agents help primary Raynaud's phenomenon 174
The safety of iloprost in systemic sclerosis in a real-life experience 174
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 173
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 168
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 166
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 161
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 156
Effects of rituximab in connective tissue disorders related interstitial lung disease 156
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 155
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 154
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 153
Oral lactobacillus species in systemic sclerosis 153
Prognostic value of lung ultrasound B-lines in systemic sclerosis 151
Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life 150
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 150
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 148
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 147
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 146
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 146
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 146
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 146
Combination therapy with Bosentan and Sildenafil improves Raynaud’s phenomenon and fosters the recovery of microvascular involvement in systemic sclerosis 146
The Use and Utility of Machine Learning in Achieving Precision Medicine in Systemic Sclerosis: A Narrative Review 143
Decreased expression of the endothelial cell-derived factor EGFL7 contributes to impaired angiogenesis and vasculogenesis in systemic sclerosis 143
Bosentan blocks the antiangiogenic effects of sera from systemic sclerosis patients: an in vitro study 143
ORAL MICROBIOME IN RHEUMATIC DISEASES.WHAT INVOLVEMENT? 142
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS) 142
Evaluation of autoimmune phenomena in patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) 141
One year in review 2021: systemic sclerosis 140
THE FIRST 1000 DAYS OF LIFE AND REPRODUCTIVE DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS) 138
AB0481 Vitamin D Levels in Children, Adolescents, and Young Adults with Juvenile Onset Systemic Lupus Erythematosus: A Transversal Study 138
Cross-Sectional Evaluation of Plasma Vitamin D Levels in a Large Cohort of Italian Patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 135
PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 132
Very early versus early disease: the evolving definition of the 'many faces' of systemic sclerosis. 132
SAT0505 Severe Vitamin D Deficiency in Patients with Kawasaki Disease: its Possible Role in the Risk to Develop Coronary Artery Damage 131
The role of ultrasound in systemic sclerosis: On the cutting edge to foster clinical and research advancement 129
Systemic sclerosis and primary biliary cholangitis: An overlapping entity? 127
Stressful life events at the onset and during the evolution of systemic sclerosis 127
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 123
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case–control study from the Italian national multicenter “SPRING” (Systemic Sclerosis Progression InvestiGation) Registry 122
Severe vitamin D deficiency in patients with Kawasaki disease: a potential role in the risk to develop heart vascular abnormalities? 121
Recent advances steer the future of systemic sclerosis toward precision medicine 119
Systemic sclerosis and primary biliary cholangitis: Longitudinal data to determine the outcomes 112
Lung vascular changes as biomarkers of severity in systemic sclerosis–associated interstitial lung disease 108
Evidence for esophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 108
Early diagnosis of systemic sclerosis, where do we stand today? 102
Very early and early diagnosis of systemic sclerosis 93
The Burden of Interstitial Lung Involvement in Rheumatoid Arthritis: Could Lung Ultrasound Have a Role in Its Detection? A Literature Review 85
Nintedanib in rheumatoid arthritis related interstitial lung disease: real-world safety profile and risk of side effects and discontinuation 77
The emerging challenge of pain in systemic sclerosis: Similarity to the pain experience reported by Sjőgren’s syndrome patients 69
Systemic sclerosis and environment: an intriguing and still debated association 68
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY 47
Systemic sclerosis: one year in review 2022 46
Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis 44
Gastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry 34
First‐line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING‐SIR registry 32
Ultrasound evaluation of bowel vasculopathy in systemic sclerosis 31
Systemic sclerosis: one year in review 2024 30
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 22
Systemic sclerosis: one year in review 2025 20
Lung involvement in psoriatic arthritis patients: cross-sectional study on prevalence, clinical characteristics, and risk factors of a neglected comorbidity 15
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology 15
Rare in the rare: Kikuchi-Fujimoto disease associated with connective tissue disorders. A report of our experience 15
Prevalence, distribution and associations of the scleroderma capillaroscopic patterns: new insights from the Italian SPRING-SIR registry 13
Pulmonary Arterial Hypertension Incidence in Patients With Systemic Sclerosis Treated With Bosentan for Digital Ulcers: Evidence From the SPRING-SIR Registry 10
Age and onset timing of Raynaud’s phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR) 9
Nintedanib in Rheumatoid Arthritis-Related Interstitial Lung Disease: Real-World Safety Profile and Risk of Side Effects and Discontinuation 8
Real-world effectiveness and retention rate of upadacitinib in patients with rheumatoid arthritis: results from a multicentre study 8
Totale 11.326
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022289 9 13 29 9 19 27 2 24 19 14 32 92
2022/2023900 90 212 34 45 57 139 123 44 84 18 28 26
2023/2024468 11 47 61 16 35 80 22 88 6 56 30 16
2024/20253.319 88 289 183 509 807 416 164 233 153 116 161 200
2025/20264.754 496 575 470 364 597 155 462 220 298 310 312 495
Totale 11.326